A comparison of data from two surveys of large, nationally representative samples of adults in the US general population ... that the prevalence of chronic kidney disease (CKD) has increased ...

ProKidney is dropping an ex-US Phase III study for its chronic kidney disease (CKD) cell therapy rilparencel, following ...

The US Food and Drug Administration (FDA) has broadened the approval of Furoscix® (furosemide injection) to treat edema in ...

Chronic kidney disease affects one in seven adults in the US, leading to serious health problems. Learn if it can be reversed ...

"Learn about the importance of kidney health and comprehensive screening during National Kidney Month. Discover how CarelonRx ...

According to the Centers for Disease Control and Prevention (CDC), CKD may affect 1 in 7 adults in the United States or 14% of the population. The CDC estimates that 9 in 10 adults with CKD do not ...

There are estimated to be around 500,000 people who need dialysis for CKD at any time in the US, and almost 90% of dialysis patients are treated for anaemia. Vafseo can be used in patients who ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm occurs. Key risk factors include diabetes, high blood pressure ...

Updates on chronic kidney disease (CKD) diagnosis, use of sodium–glucose cotransporter-2 (SGLT-2) inhibitors as first-line therapy, and personalized treatment approaches for kidney and ...

Akebia estimates there are around 550,000 patients with stage 4 or 5 CKD who are anemic and not receiving dialysis, though the company asserts that just 25% of those patients are currently treated ...